The Host-Cell Architectural Protein HMG I(Y) Modulates Binding of Herpes Simplex Virus Type 1 ICP4 to Its Cognate Promoter  by Panagiotidis, Christos A. & Silverstein, Saul J.
g
a
1
k
(
i
g
r
(
t
v
t
p
l
t
i
D
1
s
F
M
g
(
e
1
a
H
n
T
5
Virology 256, 64–74 (1999)
Article ID viro.1999.9607, available online at http://www.idealibrary.com on
0
C
AThe Host-Cell Architectural Protein HMG I(Y) Modulates Binding of Herpes Simplex
Virus Type 1 ICP4 to Its Cognate Promoter
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The productive infection cycle of herpes simplex virus is controlled in part by the action of ICP4, an immediate-early gene
product that acts as both an activator and repressor of transcription. ICP4 is autoregulatory, and IE-3, the gene that encodes
it, contains a high-affinity binding site for the protein at its cap site. Previously, we had demonstrated that this site could be
occupied by proteins found in nuclear extracts from uninfected cells. A HeLa cell cDNA expression library was screened with
a DNA probe containing the IE-3 gene cap site, and clones expressing the architectural chromatin proteins HMG I and HMG
Y were identified by this technique. HMG I is shown to augment binding of ICP4 to its cognate site in in vitro assays and to
enhance the activity of this protein in short-term transient expression assays. © 1999 Academic Pressr
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rINTRODUCTION
Expression of herpes simplex virus type 1 (HSV-1)
enes during the course of a lytic infection proceeds in
temporally ordered cascade (Honess and Roizman,
974). The virus genes are classified in three major
inetic classes, immediate-early (IE), early (E), and late
L), based on their temporal pattern of expression during
nfection (Honess and Roizman, 1974, 1975). The IE
enes, which are the first to be expressed, encode four
egulators of gene expression [infected-cell proteins
ICPs) 4, 27, 0, and 22), and a protein, ICP47, that facili-
ates immune evasion by blocking the presentation of
iral antigens (Hill et al., 1995; York et al., 1994). Regula-
ion of virus gene expression by the IE proteins takes
lace at both the transcriptional and posttranscriptional
evels. Transcriptional regulation is orchestrated by ICP4,
he major transcriptional regulator of HSV-1. ICP4, which
s essential for virus replication (DeLuca et al., 1985;
ixon and Schaffer, 1980; Knipe et al., 1978; Preston,
979; Watson and Clements, 1978, 1980), is a sequence-
pecific DNA-binding protein (DiDonato et al., 1991;
aber and Wilcox, 1986; Michael and Roizman, 1989;
ichael et al., 1988) that can act as a repressor of IE
ene expression and as an activator of E and L genes
DeLuca et al., 1985; Gelman and Silverstein, 1985; Lium
t al., 1996; O’Hare and Hayward, 1985a; Roberts et al.,
988; Watson and Clements, 1980). The IE proteins ICP0
nd ICP22, although not essential for completion of an
SV-1 lytic cycle, appear to participate in transcriptional
1 Present address: Department of Pharmacology and Pharmacog-
osy, School of Pharmacy, Aristotle University of Thessaloniki, 540 06
hessaloniki, Greece.
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opyright © 1999 by Academic Press
ll rights of reproduction in any form reserved.
64egulation as well. ICP0, a promiscuous transactivator of
iral and cellular promoters (Everett, 1984; Gelman and
ilverstein, 1985; O’Hare and Hayward, 1985a, 1985b;
uinlan and Knipe, 1985), acts at the level of transcrip-
ion (Jordan and Schaffer, 1997). ICP22 might also affect
ranscription of HSV-1 genes by altering the phosphory-
ation state of RNA polymerase II (Rice et al., 1995).
Post-transcriptional regulation of gene expression is
ffected both negatively and positively by the essential
rotein ICP27 (Everett, 1986; Hardwicke et al., 1989; Mc-
arthy et al., 1989; Rice and Knipe, 1990; Sacks et al.,
985; Sekulovich et al., 1988; Su and Knipe, 1989). The
nhibitory effects of ICP27 result from inhibition of pre-
RNA splicing (Hardy and Sandri-Goldin, 1994; Phelan
t al., 1993; Sandri-Goldin and Mendoza, 1992), whereas
ts positive effects have been linked to its ability to
romote 39 end maturation of certain RNA transcripts
McGregor et al., 1996; McLauchlan et al., 1989, 1992;
andri-Goldin and Mendoza, 1992) and possibly aid their
ucleocytoplasmic transport (Sandri-Goldin, 1998, Soli-
an, 1997). Recent evidence also suggests that ICP27
ay act at the level of transcription (Panagiotidis et al.,
997; Samaniego et al., 1995).
Although ICP4 appears to be the master switch in the
oordinated temporal expression of HSV-1 genes (for a
eview, see Roizman and Sears, 1996), its exact molec-
lar mechanism of action is largely unknown. Several
ines of evidence suggest that it is involved in a large
umber of interactions with both viral and host proteins.
CP4 has been found to interact with the TATA binding
rotein (TBP), the basal transcription factor TFIIB, and
he TBP-associated protein 250 (TAF250) (Carrozza and
eLuca, 1996; Gu and DeLuca, 1994; Gu et al., 1995;
mith et al., 1993). Therefore, it is possible that ICP4
egulates transcription by affecting transcription preini-
t
H
e
i
(
1
t
h
M
a
l
(
a
b
i
m
i
f
t
b
g
a
r
p
h
b
D
a
t
(
t
s
v
r
t
p
H
g
p
b
r
s
S
s
p
c
s
a
(
c
e
t
p
1
a
v
a
e
p
p
g
t
r
c
P
c
t
H
1
a
(
c
1
c
I
s
b
t
b
f
b
a
I
l
r
s
(
H
s
t
T
D
p
c
t
I
v
o
c
l
w
a
(
I
a
65VIRUS REPLICATION/GENE EXPRESSIONiation complex assembly. ICP4 also interacts with the
SV-1 regulatory proteins ICP0 and ICP27 (Panagiotidis
t al., 1997), and these interactions appear to affect the
ntracellular compartmentalization of these proteins
Mullen et al., 1995; Zhu et al., 1994; Zhu and Schaffer,
995). This imposition of compartmental constraints by
he virus regulatory proteins on each other is likely to
ave an impact on regulation of virus gene expression.
oreover, these interactions could alter the biochemical
ctivities of the proteins involved. Indeed, the post-trans-
ational modification state of ICP4 is affected by ICP27
McMahan and Schaffer, 1990; Rice and Knipe, 1988; Su
nd Knipe, 1989; Xia et al., 1996). Although the molecular
asis for this phenomenon is not known, it is likely to
nvolve physical interactions between ICP27 and hypo-
odified forms of ICP4 (Panagiotidis et al., 1997). This
nteraction may affect transcription because less modi-
ied forms of ICP4 have different DNA-binding specifici-
ies (Michael et al., 1988). In fact, the ability of ICP4 to
ind a regulatory region within the thymidine kinase (TK)
ene depends on the presence of ICP27 (Panagiotidis et
l., 1997).
The ability of ICP4 to interact with DNA, and thus
egulate gene expression, can also be affected by com-
onents of the cell milieu that alter DNA structure. We
ave shown that polyamines (biological cations, which
ind to and neutralize the anionic phosphate charges of
NA (Tabor and Tabor, 1984), enhance the DNA-binding
ctivity of ICP4 at physiological concentrations (Panagio-
idis et al., 1995). A recent report by Carrozza and DeLuca
1998) revealed that the high-mobility group (HMG) pro-
ein HMG 1 augments ICP4 activation of in vitro tran-
cription. Therefore, it appears that the intracellular en-
ironment of the host can influence the recognition of
egulatory DNA sequences by ICP4 and affect its ability
o regulate HSV-1 gene transcription. In this report, we
rovide evidence that the architectural chromatin protein
MG I(Y) binds to DNA sequences within the HSV-1 IE-3
ene promoter/regulatory region. This interaction ap-
ears to have regulatory significance because it affects
oth the transcriptional activity of this gene regulatory
egion and the binding of ICP4 to these same DNA
equences.
RESULTS
creening for host-cell proteins interacting with DNA
equences recognized by ICP4
Factors affecting the binding of ICP4 to DNA have the
otential to regulate virus gene expression. Physiologi-
al concentrations of the polyamines spermidine and
permine can enhance the binding of ICP4 to a high-
ffinity site positioned at the cap site of the IE-3 gene
Panagiotidis et al., 1995). This same site is readily oc-
upied by proteins prepared from uninfected cell nuclear
xtracts (Papavassiliou and Silverstein, 1990b). The fact
hat polyamines also enhanced the binding of a host-cellrotein or proteins to the same DNA (Panagiotidis et al.,
995) raised the possibility that the binding of ICP4 might
lso be affected by host-cell proteins binding in the
icinity of its DNA-binding site. To test this hypothesis,
nd to identify the factors involved, a HeLa cell cDNA
xpression library, in phage l gt11, was screened in the
resence of 1 mM spermidine with a radiolabeled DNA
robe containing six concatamerized copies of the IE-3
ene cap region (217/132). Phages expressing proteins
hat bind specifically to the IE-3 cap were verified by
epeating the screening procedure three times. The
DNAs contained in these phages were amplified by
CR and cloned. DNA sequencing of three positive
lones revealed two encoding for the chromatin archi-
ectural protein HMG I and one encoding for its isoform
MG Y (Eckner and Birnstiel, 1989; Johnson et al., 1988,
989). These proteins are encoded by the same gene,
nd their mRNAs are generated by alternative splicing
Johnson et al., 1989). HMG I, the larger of the two, is
omposed of 107 amino acids, whereas HMG Y lacks an
1-amino-acid sequence of unknown functional signifi-
ance. These proteins are commonly referred to as HMG
(Y) because no functional differences have been found
o far between these two isoforms.
To confirm the results of the library screening, recom-
inant HMG I (rHMG I) carrying a hexahistidine tag fused
o its amino terminus was expressed in bacteria, purified
y nickel-binding affinity chromatography and assayed
or its ability to bind to the IE-3 cap DNA. Protein–DNA-
inding reactions were performed with increasing
mounts of purified rHMG I (1–50 ng) and end-labeled
E-3 gene cap site probe, and the complexes were ana-
yzed by electrophoretic mobility shift assay (EMSA). The
esults of this analysis confirmed that rHMG I forms
table complexes with DNA containing the IE-3 cap site
Fig. 1A, lanes 3–6).
MG I(Y) enhances ICP4 binding to the IE-3 gene cap
ite
The aim of the present study was to identify proteins
hat potentially alter the DNA-binding activity of ICP4.
herefore, we next asked whether HMG I(Y) affects the
NA-binding activity of ICP4 to the IE-3 gene cap site
robe using recombinant HMG I(Y). The addition of in-
reasing amounts of purified rHMG I to reactions con-
aining 10 ng of a purified GST-fusion protein with the
CP4 DNA-binding domain (amino acids 245–523) re-
ealed that HMG I(Y) enhances the DNA-binding activity
f ICP4. In the absence of rHMG I, GST–ICP4–DNA
omplexes were barely detectable by EMSA (Fig. 1B,
anes 2–5). However, the abundance of these complexes
as greatly enhanced with the addition of increasing
mounts of rHMG I to the DNA-binding reaction mixture
Fig. 1B, lanes 2–5). Furthermore, the abundance of GST–
CP4–DNA complexes in the presence of increasing
mounts of rHMG I was higher than that observed when
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66 PANAGIOTIDIS AND SILVERSTEINhe DNA-binding reaction was performed in the absence
f nonspecific competitor DNA (Fig. 1A, lane 2). This
liminates the possibility that the enhancement of the
NA-binding activity of ICP4 by rHMG I results from
itration of the nonspecific sonicated salmon sperm DNA
ompetitor by rHMG I.
The effect of HMG I on the DNA-binding activity of
ull-length ICP4 was also measured using nuclear ex-
racts from HSV-1-infected HeLa cells as the source of
CP4. The addition of increasing amounts of rHMG I
esulted in an increase in the accumulation of an ICP4-
NA complex (Fig. 2, lanes 3–6). Supershift analysis
sing 58S monoclonal antibody (MAb) confirmed that
CP4 was present in the HMG I-enhanced protein–DNA
omplex (Fig. 2, lanes 7–10). The results of this analysis
emonstrate that the effect of HMG I is not limited to the
acterially expressed, purified DNA-binding domain of
CP4 but that it can be reproduced with the full-length
CP4. Furthermore, because rHMG I does not enhance
he formation of other IE-3 cap site–protein complexes
Fig. 2), we believe that the HMG I effect is specific only
or the binding of ICP4 to the IE-3 cap site and not for
ther IE-3 cap site-binding proteins. Further evidence for
he specificity of the HMG I effect comes from our ob-
ervation that HMG I does not enhance the binding of
CP4 to the TK B region of the HSV-1 TK gene that is
FIG. 1. Binding of rHMG I to the IE-3 cap site and its effects on the
NA-binding activity of a recombinant ICP4 protein. The ability of
urified rHMG I to bind the IE-3 cap site, as well as its effect on the
NA-binding activity of a purified, bacterially expressed, fusion of the
NA-binding domain of ICP4 (amino acids 245–523) with GST (GST-
CP4), was assessed by EMSA. The DNA-binding reactions were per-
ormed as described in Materials and Methods, and the amounts of
HMG I added to each reaction mix are indicated above the figure. The
mount of GST-ICP4 used was 10 ng (A, lanes 2–6; B, lanes 1–5).
onicated salmon sperm DNA (0.5 mg/reaction) was used as nonspe-
ific competitor except in A, lane 2 (No comp), where no competitor
as added. The positions of the unbound IE-3 cap probe and the
HMGI–DNA and ICP4–DNA complexes are indicated.ound by ICP4 (Papavassiliou and Silverstein, 1990b),
hich lacks an HMG I site and is not bound by the
rotein (data not shown).
HMG I(Y) binds the minor groove of DNA at AT-rich
egions (Solomon et al., 1984; Thanos and Maniatis,
992). To further demonstrate that the enhanced binding
as specific, a poly(dA)/poly(dT) polynucleotide was
sed as a specific competitor and poly(dG)/poly(dC) was
sed as a nonspecific competitor in binding reactions.
he resulting protein–DNA complexes were analyzed by
MSA. The addition of increasing amounts of either
olynucleotide had little, if any, effect on the abundance
CP4–DNA complexes in the absence of exogenous
HMG I (Fig. 3, lanes 2–7). As expected, the addition of
HMG I to the binding reactions greatly increased the
bundance of ICP4–DNA complexes (Fig. 3, compare
anes 2 and 8). However, only poly(dA)/poly(dT) com-
eted for formation of both the rHMG I–DNA complexes
nd the HMG I-enhanced ICP4 complexes (Fig. 3, lanes
–13). The decrease in the abundance of ICP4–DNA
omplexes paralleled that of HMG I-DNA complexes, as
ould be expected for an HMG I-specific effect (Fig. 3).
imilar data are also obtained when distamycin, an oli-
opeptide antibiotic, is added to the binding reactions.
istamycin binds in the minor groove of DNA with similar
pecificity to HMG I(Y) (Bellorini et al., 1995; Mote et al.,
994). It also competes with HMG I(Y) for binding to DNA
FIG. 2. Enhancement of ICP4 binding by rHMG I. Protein–DNA-
inding reactions and EMSAs were performed as described in Mate-
ials and Methods using nuclear extracts from HSV-1-infected HeLa
ells, except in lane 2, where an extract from mock-infected cells was
sed. Five micrograms of HeLa nuclear extract proteins and 2 mg of
onspecific competitor DNA were used in each binding experiment.
he amounts of rHMG I added to each binding reaction are indicated
bove the figure. Supershift analysis was performed using 1 mg of
urified 58S MAb per reaction (lanes 7–10). The positions of the
nbound IE-3 cap probe and the ICP4–DNA and MAb–ICP4-DNA com-
lexes are indicated.
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67VIRUS REPLICATION/GENE EXPRESSIONFrench et al., 1996; Ghersa et al., 1997). We verified this
esult, using the IE-3 cap site probe, and found that
istamycin also competed with the HMG I-enhanced
inding of ICP4 to DNA, whereas it did not affect the
inding of ICP4 in the absence of exogenously added
MG I (data not shown).
dentification of the HMG I(Y) binding sites within the
E-3 promoter/regulatory region
DNase I protection footprint analysis was used to
dentify DNA sites within the IE-3 regulatory region that
re bound by HMG I(Y). This analysis revealed that
HMG I protected, albeit weakly, two DNA sequences
from 22 to 24 and from 19 to 112, relative to the
ranscription start site) within the IE-3 cap site (Fig. 4).
he weak protection by rHMG I is not unexpected be-
ause the IE-3 gene cap site bears little resemblance to
equences typically recognized by HMG I(Y). The addi-
ion of more rHMG I (at 120 and 200 ng) to the reactions
esulted in DNase I hypersensitivity at two positions (16
nd 28) within the IE-3 cap site (Fig. 4). This may indi-
ate that rHMG I binding to the IE-3 cap alters DNA
tructure. This putative alteration may facilitate the in-
reased binding of ICP4 to this sequence.
The DNase I footprint analysis revealed that rHMG I
inds to the IE-3 cap site and to two other sequences
ithin the IE-3 promoter. One of these sites (from 226 to
21) corresponds to the TATA box. The strongest rHMG
-dependent protection within the IE-3 probe was ob-
erved further upstream (2106 to 298) at the DNA re-
ion overlapping the TAATGARAT motif. The binding of
FIG. 3. Specificity of rHMG I enhancement of ICP4 binding. DNA-
inding reactions with nuclear extracts from HSV-1-infected (7 h) HeLa
ells and EMSAs were performed as described in Materials and Meth-
ds. Reactions were performed in the absence (2HMG I, lanes 1–7) or
resence (1HMG I, lanes 8–13) of 100 ng of rHMG I. The amounts of
oly(dA)/poly(dT) and poly(dG)/poly(dC) competitor polynucleotides are
hown above the figure. No competitor was added in the reactions
nalyzed in lanes 2 and 8. The reaction in lane 1 (M) was performed
sing a nuclear extract from mock-infected HeLa cells. Arrows indicate
he positions of the free IE-3 probe and its complexes with rHMG I or
CP4.MG I(Y) to several sites within the IE-3 gene promoter/
egulatory region is consistent with the multivalent bind-
ng of this protein to several other promoters where it has
FIG. 4. DNase I footprinting analysis of HMG I binding sites within
he IE-3 gene promoter/regulatory region. The reactions were per-
ormed as described in Materials and Methods with the indicated
mounts of rHMG I added to each reaction. The black boxes at the left
dentify regions protected from DNase I action in the presence of rHMG
. The asterisks identify sites that become hypersensitive to DNase I
ction in the presence of rHMG I. The boxed sequences contain the
ATA box and a high-affinity ICP4 recognition site. The arrow at 11
dentifies the IE-3 gene transcription initiation site.
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68 PANAGIOTIDIS AND SILVERSTEINeen found to alter DNA architecture (Carey, 1998; Maher
nd Nathans, 1996; Thanos and Maniatis, 1995).
MG I(Y) potentiates the repressive effect of ICP4 on
he IE-3 promoter
ICP4 binding to IE-3 promoter sequences results in
epression of gene expression. Thus if in vivo HMG I(Y)
nhances the binding of ICP4 to the IE-3 promoter, as it
oes in vitro, then it should enhance repression by ICP4.
o test this hypothesis, the ability of ICP4 to repress the
E-3 promoter was measured in transfection experiments
n the presence or absence of coexpressed HMG I. Vero
ells were transfected with an IE-3 promoter-luciferase
eporter construct and increasing amounts (10 ng to 1.5
g) of a plasmid expressing ICP4 under the control of a
ytomegalovirus (CMV) promoter, in the presence or ab-
ence of 1 mg of a CMV promoter-driven HMG I con-
truct. As expected, ICP4 activated the IE-3 promoter at
ow ratios of ICP4 to IE-3 promoter-luciferase construct
ut repressed it when cotransfected at higher ratios (Fig.
). However, the repressive effect of ICP4 on the IE-3
romoter was significantly enhanced when HMG I was
oexpressed (Fig. 5). Specifically, the amount of input
MV-ICP4 DNA required to effect 50% repression was
educed from 750 ng, in the absence of coexpressed
MG I, to 40 ng in its presence. Similar results were also
btained with a construct expressing HMG Y (data not
hown).
It was possible that the enhanced expression was
aused by HMG I-mediated activation of the CMV pro-
oter that was driving the expression of ICP4. If this
ere the case, then overproduction of ICP4 should gen-
FIG. 5. Cotransformation of plasmids expressing rHMG I and ICP4.
nd the indicated amounts of pCPC-CMV4. These transfections were p
arvested at 36 h postinfection, and luciferase activities were determi
ercentage of the luciferase activity value (relative light units) obtained f
lasmids.rate similar results. Therefore, we determined the effect
f cotransfecting a plasmid expressing HMG I with a
MV promoter-luciferase reporter construct on the activ-
ty of the CMV promoter. HMG I had only a very small
ffect (,5%) on the activity of the CMV promoter (data not
hown). Thus the HMG I(Y)-mediated enhancement of
he DNA-binding activity of ICP4 can take place not only
n vitro but also within the intracellular milieu.
ffect of HMG I(Y) on the activity of the IE-3
romoter
HMG I(Y) is neither a transcriptional activator nor re-
ressor (Carey, 1998; Thanos and Maniatis, 1992, and
eferences therein). However, in its function as an archi-
ectural protein (Bustin and Reeves, 1996), it can alter the
onformation of DNA-regulatory regions affecting the
inding of transcriptional activators and repressors. The
dentification of three HMG I(Y) binding sites in the IE-3
ene promoter/regulatory region suggests that HMG I(Y)
ay alter the architecture of this promoter and affect its
asal activity. To test this hypothesis, Vero cells were
ransfected with the IE-3 promoter-luciferase reporter
onstructs (1 mg) and increasing amounts (0.1 mg-2 mg)
f plasmids expressing HMG I or antisense HMG I(Y)
NA, each of which was under the control of a CMV
romoter. HMG I expression increased the activity of the
E-3 promoter by more than twofold, whereas expression
f the antisense HMG I(Y) RNA resulted in a modest
eduction (;30%) of the IE-3 promoter activity (Fig. 6). It
s noteworthy that expression of either HMG I(Y), or the
ntisense HMG I(Y) RNA has no effect on the activity of
he minimal IE-3 promoter (2108 to 132) reporter con-
lls were transfected with 1 mg of the reporter plasmid pCPC-4P-LUC
ed in the absence (E) or presence (M) of 1 mg of pCPC-IE. Cells were
described in Materials and Methods. The results are expressed as a
ls transfected with the reporter construct in the absence of any effectorVero ce
erform
ned as
rom cel
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69VIRUS REPLICATION/GENE EXPRESSIONtruct pCPC-4P1-LUC (Fig. 6). This minimal promoter
ontains two of the three HMG I(Y) binding sites (at the
E-3 cap site and at the TATA box). However, it lacks the
hird site that overlaps with the TAATGARAT motif and
ther binding sites for transcription factors that interact
urther upstream of the minimal IE-3 promoter. Despite
he absence of this upstream HMG I binding site, there is
o diminution of the HMG I effect on ICP4-mediated
epression. Indeed, the addition of HMG I enhanced the
epressive effect of ICP4 even when plasmid pCPC-
P-1-LUC was used as the reporter (data not shown).
hese results suggest that HMG I(Y) positively affects
he activity of the IE-3 promoter. Increased reporter ac-
ivity requires the upstream sequences that are bound by
ranscription factors that recognize DNA sequences
ithin this regulatory region, such as Sp1 and Oct-1. In
ddition, HMG I, by changing the architecture of the
romoter, might facilitate contacts between transcription
actors and the transcription preinitiation complex.
DISCUSSION
The highly ordered temporal expression of HSV-1
enes is primarily effected by ICP4, the major virus
egulatory protein (for a review, see Roizman and Sears,
996). Although the exact molecular mechanism or
echanisms of the action of ICP4 are largely unknown, it
as been shown to act as a transcriptional repressor of
E genes and an activator of E and L genes. DNA binding
lays an important role in the regulatory activities of ICP4
Shepard et al., 1989). Therefore, factors that affect the
FIG. 6. Effect of HMG I on the activity of the IE-3 gene promoter. Vero
ells were transfected with 1 mg of pCPC-4P-LUC (F and f) or pCPC-
P1-LUC (E and M) and the indicated amounts of pCPC-IE (HMG I, F
nd E) or the HMG I(Y) antisense plasmid pa-HMG I (f and M). Cells
ere harvested at 36 h postinfection, and luciferase activities were
etermined as described in Materials and Methods. The results are
xpressed as described in Fig. 5.NA-binding activity of ICP4 have the potential to mod-
late HSV-1 gene expression.
We previously demonstrated that a high-affinity bind-
ng site for ICP4, located at the transcriptional start site
f the IE-3 gene, was bound by host proteins extracted
rom uninfected cells (Panagiotidis et al., 1991; 1995).
his present study was initiated to identify host proteins
hat occupy sites in the HSV-1 chromosome that are
ubsequently bound by ICP4 after infection. The ICP4
NA-binding site used in this analysis represents one of
he most studied sites in the virus chromosome. More-
ver, the biological consequences of ICP4 binding can
e readily assessed, (i.e., ICP4 binding leads to IE-3
ene repression) (DeLuca et al., 1985; Gelman and Sil-
erstein, 1985; O’Hare and Hayward, 1985a; Roberts et
l., 1988). Analysis of a HeLa cDNA expression library
ith a DNA probe containing the high-affinity binding site
or ICP4 revealed that the chromatin architectural pro-
eins HMG I and HMG Y bound to the probe. Binding of
MG I(Y) to the IE-3 cap site was further verified by in
itro experiments with purified recombinant HMG I
Fig. 1).
HMG proteins are a heterogeneous group of small,
cid-soluble, non-histone chromatin proteins (Bustin and
eeves, 1996). They are classified in three general fam-
lies: the HMG1/2, the HMG 14/17, and the HMG I(Y)
amilies (Bustin and Reeves, 1996, and references
herein). It was initially thought that HMGs represent
tructural components of the eucaryotic chromatin with
imited gene-regulatory potential. They are now known to
e involved in a wide variety of cellular functions involv-
ng DNA, such as transcription, replication, and recom-
ination (Bustin and Reeves, 1996; Carey, 1998; Falvo et
l., 1995; Fashena et al., 1992; Ogawa et al., 1995; Thanos
nd Maniatis, 1992, 1995). HMGs exert their effects by
odifying chromatin architecture and/or by functionally
nteracting with regulatory and structural protein compo-
ents of the chromatin (Bustin and Reeves, 1996; Carey,
998; Falvo et al., 1995; Fashena et al., 1992; Ogawa et
l., 1995; Thanos and Maniatis, 1992, 1995). HMG I(Y)
inds to the minor groove of AT-rich DNA regions through
hree short basic amino acid repeats called the AT-hooks
Reeves and Nissen, 1990). Although not a transcriptional
ctivator per se, HMG I(Y) influences the activity of sev-
ral cellular and viral promoters (for a review, see Carey,
998). It produces its effects in multiple ways by: facili-
ating transcription factor binding to DNA, stabilizing
igher-order multiprotein–DNA transcription-enhancing
enhanceosome) complexes, or competing with histone-
ediated repression (Carey, 1998).
In this study, we demonstrate that HMG I(Y) induces
he in vitro binding of both full-length ICP4 and a GST-
usion with the ICP4 DNA-binding domain to the IE-3 cap
ite DNA probe (Figs. 1 and 2). HMG I(Y) is known to
xert its effects not only by altering the DNA structure but
lso by physically interacting with several transcription
actors (Lehming et al., 1994; Thanos and Maniatis, 1992;
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70 PANAGIOTIDIS AND SILVERSTEINood et al., 1995; Zhou and Chada, 1998). Therefore, its
ffects on ICP4 could be a result of HMG I(Y)-induced
NA conformational change or changes and/or protein–
rotein interactions between HMG I(Y) and ICP4. How-
ver, despite repeated efforts using both immunoprecipi-
ation and protein capture techniques, no evidence was
ound for protein–protein interactions between HMG I(Y)
nd ICP4. In contrast, binding of HMG I(Y) to the IE-3 cap
NA results in DNase I hypersensitivity of two bases in
he vicinity of HMG I(Y) binding sites (Fig. 4). This hyper-
ensitivity is indicative of HMG I(Y)-induced DNA confor-
ational changes that could result in the enhancement
f ICP4 binding in the presence of HMG I(Y).
ICP4 binding to the IE-3 gene cap site results in re-
ression (Roberts et al., 1988). The enhanced binding of
CP4 in the presence of HMG I in vitro suggested to us
hat ICP4 binding in the presence of HMG I(Y) should
otentiate the repressive effect of ICP4 in vivo. This
ypothesis was tested in transfection experiments, and
he HMG I and HMG Y isoforms were found to be equally
ffective in enhancing the repressing activity of ICP4 on
he IE-3 promoter. These results indicate that HMG I(Y)
as the potential to modulate the activity of ICP4 and,
onsequently, virus gene expression.
HMG I(Y), unlike other HMG-box containing proteins
hat induce sharp bends in the DNA structure, has only a
elative modest effect on DNA conformation (Carey, 1998;
alvo et al., 1995). However, it frequently binds to multiple
ites within target promoters, and this multivalent bind-
ng could produce extensive changes in chromatin ar-
hitecture that might be essential for its effects on the
inding of transcription factors. HMG I(Y) binds to at
east three sites within the IE-3 gene promoter-regulatory
equences, as shown by DNase I footprint analysis (Fig.
). Interestingly, these sites overlap with sequences that
re important in the regulation of transcription from the
E-3 gene. These sequences include the TATA box, the
AATGARAT element, and the ICP4 binding site. Protec-
ion of these DNA elements suggests that the role of
MG I(Y) in the regulation of IE-3 gene expression is not
imited to its effects on ICP4. Indeed, in transfection
xperiments, HMG I(Y) enhances the basal activity of the
E-3 promoter in the absence of viral factors (Fig. 6). A
urther role for HMG I(Y) in regulating transcription from
his promoter is suggested by its failure to activate a
inimal IE-3 promoter lacking the HMG I(Y) binding site
hat overlaps with the TAATGARAT sequence. This result
uggests that multivalent HMG I(Y) binding to the IE-3
romoter/regulatory sequences is essential for its func-
ion. Alternatively, HMG I(Y) might recruit transcription
actors that bind to upstream sequences that are missing
rom the minimal IE-3 promoter and/or it might facilitate
he effects of upstream binding factors on the transcrip-
ion preinitiation complex. To discriminate among these
ossibilities or to identify alternatives will require further
xperimentation.
The results presented here indicate that architecturalrotein components of the host cell chromatin may mod-
late HSV-1 gene expression by affecting the binding of
ost and virus-encoded transcription regulatory proteins.
e do not at present know whether HMG I(Y) affects
ther classes of HSV-1 promoters. The recent observa-
ion (French et al., 1996) that HMG I(Y) binds to and
odulates the activity of another HSV-1 promoter, the
atency-active promoter 2 (LAP-2), points toward a more
eneral role for HMG I(Y) in the regulation of virus gene
xpression. This study provides further evidence that
rchitectural proteins can play a significant role in the
egulation of HSV-1 gene expression.
MATERIALS AND METHODS
ells and virus
Vero cells were grown and maintained in DMEM
GIBCO BRL, Grand Island, NY) containing 5% bovine calf
erum (Hyclone Laboratories Inc., Logan, UT). The media
ere supplemented with 100 U/ml penicillin and 100
g/ml streptomycin (GIBCO BRL), unless otherwise
oted. HeLa cells were propagated in monolayers as
reviously described (Papavassiliou and Silverstein,
990a). HSV-1 strain 17 was used in this study.
creening of the HeLa cDNA expression library with
DNA probe
The HeLa cDNA library, was constructed in the l gt11
fi–Not vector (Promega, Madison, WI) by Jeh-Ping Liu
nd Scott Zeitlin (Columbia University). A 32P end-labeled
50-bp HindIII–EcoRI restriction fragment from plasmid
CPC-1B (see below) was used to screen ;750,000
laques from the expression library for clones that pro-
uced protein that was bound by the probe. This DNA
ragment contained six randomly concatamerized copies
f the 217/132 sequence from the HSV-1 IE-3 gene. The
creening of the cDNA expression library was performed
s previously described with some modifications (Singh
t al., 1988). Filters were blocked with Blotto overnight at
°C, with gentle agitation. The incubation was performed
n 10 mM Tris–HCl, pH 7.5, 50 mM NaCl, 5% (v/v) glycerol,
mM EDTA, 4 mM dithiothreitol, and 0.2 mg/ml BSA, and
.5 mM spermidine and salmon sperm DNA (100 mg/ml)
as used as the nonspecific competitor. Positive
laques were isolated, verified by rescreening, and pu-
ified three times. The cDNA inserts were amplified by
CR using l gt11 primers (Promega), and the amplimers
ere cloned into the TA cloning vector pCRII (InVitrogen,
an Diego, Ca.). The DNA sequence of each clone was
etermined using an ABI 377 automated sequencer (Per-
in–Elmer, Foster City, CA) by the Columbia Cancer Cen-
er sequencing facility.
lasmid constructions
Plasmid pCPC-1A, containing the 217/132 region of
he IE-3 gene, was constructed by subcloning an end-
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71VIRUS REPLICATION/GENE EXPRESSIONilled 49 bp AvaI–BamHI fragment from plasmid pIGA103
Gelman and Silverstein, 1987) in the HincII site of
UC19. Plasmid pCPC-1B, containing six tandem 217/
32 IE-3 gene regions, was constructed by subcloning a
elf-ligated 68-bp AvaI (filled) restriction fragment from
CPC-1A into the HincII site of pUC19. IE-3 promoter-
uciferase reporter constructs pCPC-4P-LUC (2323/132)
nd pCPC-4P1-LUC (2108/132) were constructed as
ollows. Plasmid pCPC-4P-LUC was generated by clon-
ng a BamHI fragment containing the luciferase coding
equences from plasmid p19LUC (van Zonneveld et al.,
988) into the BamHI site of pIGA103 (Gelman and Sil-
erstein, 1987). Plasmid pCPC-4P1-LUC was constructed
n two steps. First, a BamHI and EcoRI fragment from
lasmid pIGA103, containing the 2108/132 sequences
rom the IE-3 promoter, was cloned in vector pIC-20H (cut
ith BamHI–EcoR I) to yield pCPC-4P1. Plasmid pCPC-
P1-LUC was generated by cloning the BamHI fragment,
ontaining the luciferase coding sequences, from plas-
id p19LUC into the BamHI site of pCPC-4P1. Plasmids
CPC-I and pCPC-Y were constructed by ligating the
CR-amplified HMG I and HMG Y cDNAs with pCRII
InVitrogen). Plasmids pCPC-IE and pCPC-YE, which ex-
ress HMG I or HMG Y, respectively, under the control of
he CMV promoter, were generated by subcloning the
coRI (filled)–NotI fragments from plasmids pCPC-I and
CPC-Y in pcDNAI.neo (InVitrogen) that had been di-
ested with EcoRV–NotI. Plasmid panti-HMG I(Y), ex-
ressing an antisense HMG I(Y) RNA (Thanos and Ma-
iatis, 1992), was a gift from Dr. T. Maniatis, as was the
acterial expression construct pET15b-HMG I (see be-
ow). Bacterial plasmids pCPC-X4(2–5) expressing the
CP4 DNA-binding domain (amino acids 245–523) and
CPC-X4(5–6) expressing amino acids 573–686 of ICP4,
s amino-terminal fusions with GST, were previously
escribed (Panagiotidis et al., 1997).
rotein expression and purification
The GST-fusion proteins were expressed in bacteria
nd purified as previously described (Panagiotidis et al.,
997; Smith and Johnson, 1988). Recombinant HMG I
rHMG I) protein, carrying a hexahistidine tag fused at its
mino terminus, was expressed in Escherichia coli
L21(DE3) transformed with plasmid pET15b-HMG I
Thanos and Maniatis, 1992). Purification of rHMG I was
erformed by affinity chromatography on a nickel-NTA
garose column (Qiagen), as previously described (Tha-
os and Maniatis, 1992). After purification, proteins were
ialyzed overnight at 4°C against 200 volumes of 10 mM
EPES-KOH, pH 7.9, 50 mM NaCl, 1 mM EDTA, 4 mM
ithiothreitol, and 20% (v/v) glycerol, with two changes.
Protein concentrations were determined by the Brad-
ord method (Bradford, 1976), and protein purity was
etermined by SDS–PAGE (Laemmli, 1970). Proteins
ere stored in aliquots at 280°C.ransfections and luciferase assays
Transfections were performed using the calcium phos-
hate precipitation method (Wigler et al., 1979). Briefly,
ero cells were seeded at a density of 5 3 105 cells/
0-mm plate the day before transfection. The culture
edia were replaced 5 h before transfection. Transfec-
ions were performed with calcium phosphate, using 15
g of total plasmid DNA/plate, and the transfection mix-
ures were left on the cells overnight. The next day, the
ells were refed with fresh media after three washes of
he cell monolayers with PBS. The cells were harvested
t 48 h posttransfection, and luciferase activities were
etermined as described previously (Brasier et al., 1989),
sing a Berthold Lumat LB9501 luminometer (Wallac Inc.,
aithersburg, MD). Luciferase activities were deter-
ined from triplicate transfections in at least two inde-
endent experiments.
uclear extract preparation and EMSAs
Nuclear extracts were prepared from uninfected and
SV-1 infected HeLa cells at 7 h postinfection (Dignam et
l., 1983), with some modifications (Papavassiliou and
ilverstein, 1990a). EMSAs were performed by incubat-
ng either 4 mg of nuclear or total cell extracts or the
ndicated amounts of the purified proteins with 32P end-
abeled restriction fragments from the IE-3 gene (217/
32), which contains a high-affinity ICP4 binding site,
ollowed by native PAGE (Papavassiliou and Silverstein,
990a). The DNA-binding reactions were incubated for
0 min at room temperature in 10 mM Tris–HCl, pH 7.5,
0 mM NaCl, 5% (v/v) glycerol, 1 mM EDTA, 4 mM
ithiothreitol, and 0.2 mg/ml BSA in a final volume of 20
l. Sonicated salmon sperm DNA or poly(dG)/poly(dC)
Pharmacia) were included as nonspecific DNA compet-
tors. Supershift analyses were performed by adding 1
g of purified anti-ICP4 mouse MAb 58S (Showalter,
weig, and Hampar, 1981) to each binding reaction after
0 min of incubation, and the reaction mix was incubated
or an additional 30 min. The 58S MAb was equilibrated
n binding buffer by dialysis. After separation by native
AGE in 0.253 TBE, 4% gels, the DNA–protein com-
lexes were visualized by autoradiography.
Nase I footprint analysis
The DNA probe used in the footprinting experiments
as labeled on one strand by end-filling with the Klenow
ragment of DNA polymerase I. The probe was a HindIII–
coI fragment from plasmid pIGA103 (Gelman and Sil-
erstein, 1987), and it was labeled at the HindIII site.
Nase I protection experiments were performed as pre-
iously described (Panagiotidis et al., 1995), and the
roducts of the digestion were analyzed on 6% sequenc-
ng gels.
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